On August 26, 2020 IMV Inc. ("IMV" or the "Corporation") (Nasdaq: IMV; TSX: IMV), a clinical-stage biopharmaceutical company pioneering a novel class of cancer immunotherapies and vaccines against infectious diseases, reported that the IMV’s executive management team will participate at four upcoming virtual investor conferences in September (Press release, IMV, AUG 26, 2020, View Source [SID1234564044]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

LD Micro 500 Virtual Event
Date: Tuesday, September 1, 2020
Presentation Time: 3:00 p.m. Eastern Daylight Time

2020 Wells Fargo Virtual Healthcare Conference
Date: Wednesday, September 9, 2020
Presentation Time: 8:00 a.m. Eastern Daylight Time

H.C. Wainwright: 22nd Annual Global Investment Conference
Date: Monday, September 14, 2020
Presentation Time: 10:00 a.m. Eastern Daylight Time

2020 Cantor Virtual Global Healthcare Conference
Date: Wednesday, September 16, 2020
Presentation Time: 8:40 a.m. Eastern Daylight Time

A live webcast of these presentations will be available under "Events, Webcasts and Presentations" in the investors section of IMV’s website and a replay will be available approximately one hour after the presentation. Afterwards, it will be available for approximately 30 days.